Cardiol Therapeutics (CRDL) Stock Chart & Stock Price History C$2.54 -0.08 (-3.05%) (As of 11/15/2024 ET) Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlines Cardiol Therapeutics Stock Price Performance 5 Day Performance-4.87%1 Month Performance-5.58%3 Month Performance-8.30%6 Month Performance-13.31%Year-To-Date Performance+130.91%1 Year Performance+117.09% Receive CRDL Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Cardiol Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners (Ad)The "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. A tax-free gift so powerful it could reshape the financial destinies of millions of IRA and 401(k) owners…Claim your FREE 2024 Gold Guide CRDL Stock Chart for Sunday, November, 17, 2024 CRDL Chart by TradingView Cardiol Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization11/15/2024C$2.62C$2.54-3.05%C$2.62C$2.42157,580 shsC$177.50 million11/14/2024C$2.66C$2.62-1.50%C$2.73C$2.5853,391 shsC$183.09 million11/13/2024C$2.67C$2.66-0.37%C$2.76C$2.6238,617 shsC$185.88 million11/12/2024C$2.73C$2.67-2.20%C$2.73C$2.6173,353 shsC$186.58 million11/11/2024C$2.78C$2.73-1.80%C$2.86C$2.65121,700 shsC$190.77 million11/08/2024C$2.90C$2.78-4.14%C$2.91C$2.72103,405 shsC$194.27 million Get the Latest News and Ratings for CRDL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cardiol Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 11/07/2024C$2.69C$2.90+7.81%C$2.94C$2.68142,560 shsC$202.65 million11/06/2024C$2.72C$2.69-1.10%C$2.75C$2.6380,343 shsC$187.98 million11/05/2024C$2.66C$2.72+2.26%C$2.74C$2.6359,316 shsC$190.07 million11/04/2024C$2.61C$2.66+2.11%C$2.67C$2.5847,020 shsC$185.88 million11/01/2024C$2.50C$2.61+4.40%C$2.64C$2.5140,201 shsC$182.39 million10/31/2024C$2.53C$2.50-1.19%C$2.55C$2.4566,661 shsC$174.70 million10/30/2024C$2.55C$2.53-0.78%C$2.58C$2.5174,200 shsC$176.80 million10/29/2024C$2.57C$2.55-0.78%C$2.61C$2.5471,289 shsC$178.19 million10/28/2024C$2.69C$2.57-4.46%C$2.71C$2.5537,060 shsC$179.59 million10/25/2024C$2.60C$2.69+3.46%C$2.71C$2.59107,106 shsC$187.98 million10/24/2024C$2.58C$2.60+0.78%C$2.63C$2.5467,372 shsC$181.69 million10/23/2024C$2.58C$2.58C$2.62C$2.4777,822 shsC$180.29 million10/22/2024C$2.64C$2.58-2.27%C$2.64C$2.5347,611 shsC$180.29 million10/21/2024C$2.65C$2.64-0.38%C$2.66C$2.5830,350 shsC$184.48 million10/18/2024C$2.69C$2.65-1.49%C$2.71C$2.65116,324 shsC$185.18 million10/17/2024C$2.62C$2.69+2.67%C$2.69C$2.6173,857 shsC$187.98 million10/16/2024C$2.61C$2.62+0.38%C$2.67C$2.6187,505 shsC$183.09 million Related Companies Solaris Resources Stock Price Chart Aimia Stock Price Chart Andean Precious Metals Stock Price Chart Fennec Pharmaceuticals Stock Price Chart Gear Energy Stock Price Chart International Tower Hill Mines Stock Price Chart Medicenna Therapeutics Stock Price Chart Graphite One Stock Price Chart EQ Stock Price Chart CI Canadian Convertible Bond ETF Common Stock Price Chart Receive CRDL Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Cardiol Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (TSE:CRDL) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cardiol Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cardiol Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
